![Mark Casey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Casey
General Counsel bei
NOVAVAX, INC.
Vermögen: 988 035 $ am 31.05.2026
Profil
Mark Joseph Casey is currently Secretary, Chief Legal Officer & Executive VP at Novavax, Inc. since 2023.
Former roles include Secretary & Chief Legal Officer at Bryn Pharma LLC in 2023; Chief Legal Officer & Executive Vice President at Keenova Therapeutics PLC from 2018 to 2022; Secretary, Senior Vice President & General Counsel at Idera Pharmaceuticals, Inc. from 2015 to 2018; Secretary, Chief Administrative Officer & SVP at Hologic, Inc. from 2012 to 2014; Chief Legal Officer & Executive Vice President at Mallinckrodt Pharmaceuticals Ltd.; Chief Patent Counsel, VP & Deputy General Counsel at Cytyc Corp.
from 2002 to 2007; Attorney at Boston Scientific Corp.
from 1998 to 2002; Attorney at EMC Corp.
from 1996 to 1998; Attorney at Digital Equipment Corp.
from 1992 to 1996; Director at MKG Medical UK Ltd. from 2020 to 2025; Director at AdvaMedDx; Director at Third Wave Technologies, Inc. in 2008.
Education includes undergraduate studies at Syracuse University and graduate studies at Suffolk University Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC. 0,05 % | 23.04.2026 | 90 067 ( 0,05 % ) | 988 035 $ | 31.05.2026 |
Aktive Positionen von Mark Casey
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | General Counsel | 11.12.2023 |
Ehemalige bekannte Positionen von Mark Casey
| Unternehmen | Position | Ende |
|---|---|---|
MKG Medical UK Ltd.
 MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 15.01.2025 |
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | General Counsel | 01.11.2023 |
| MALLINCKRODT PLC | General Counsel | 15.09.2022 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | General Counsel | 31.01.2018 |
| HOLOGIC, INC. | Verwaltungsdirektor | 19.12.2014 |
Ausbildung von Mark Casey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
EMC Corp.
 EMC Corp. Computer PeripheralsElectronic Technology Manufactures and sells computer storage devices and provides IT services | Electronic Technology |
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Develops DNA and RNA detection technology | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdvaMedDx
 AdvaMedDx Miscellaneous Commercial ServicesCommercial Services Operates as a trade association representing diagnostics manufacturers | Commercial Services |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MKG Medical UK Ltd.
MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
